Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP binding cassette subfamily B member 8 (ABCB8) is a mitochondrial inner membrane protein and an ATP-dependent transporter. It serves as the ATP-binding regulatory subunit in the mitochondrial ATP-sensitive potassium (mitoKATP) channel complex, in partnership with the pore-forming CCDC51 protein. ABCB8 regulates potassium ion flux in response to cellular ATP levels: when ATP is high, the channel closes and inhibits K+ uptake, while low ATP opens the channel, allowing K+ entry into the mitochondrial matrix. It also plays a key role in maintaining mitochondrial iron homeostasis and proper function of cytosolic iron-sulfur cluster enzymes, which are essential for normal cardiac physiology. Mutations or dysfunction in ABCB8 may result in disease phenotypes ranging from congenital malformation (acheiropody) to possible roles in cardiac ischemic injury or oxidative stress-responsive conditions. ABCB8, as a mitochondrial sulfonylurea-receptor, is a putative pharmacological target for drugs that modulate mitochondrial potassium channel activity, though no selective molecules are currently in clinical use.
Diazoxide: opens mitochondrial ATP-sensitive potassium channels, promoting mitochondrial matrix K+ uptake, triggers mitochondrial swelling and protection against ischemia/reperfusion injury. Sulfonylureas: inhibit ATP-sensitive potassium channels by binding to sulfonylurea-receptor subunit (in plasma membrane and mitochondria).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP binding cassette subfamily B member 8, mitochondrial (ABCB8).